Increasing growth opportunities in emerging countries, increasing number of dialysis centers, and growing preference for home medical care

Global hemodialysis and peritoneal dialysis market

DUBLIN, April 29, 2024 (GLOBE NEWSWIRE) — “Global hemodialysis and peritoneal dialysis market size (by product, machine, blood system, concentrate (alkaline), catheter, dialysis machine, water treatment, service), by modality (CAPD, nighttime), by user (hospital, home Care) and Region – Forecasts to 2029” Report added ResearchAndMarkets.com Recruitment.

Global hemodialysis and peritoneal dialysis market is projected to reach USD 126.2 billion by 2029 from USD 92 billion in 2024 at a CAGR of 6.5%

Rapid growth in the global elderly population and significant increase in kidney-related diseases among patients are expected to increase the demand for the hemodialysis and peritoneal dialysis market. Additionally, the gradual increase in the utilization of home hemodialysis is likely to support the market growth. Advances in dialysis treatment technology and government policies, investments in healthcare infrastructure, and efforts to increase the accessibility of dialysis services are expected to drive market growth.

The major players operating in the hemodialysis and peritoneal dialysis market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (USA), Braun Melsungen AG (Germany), and Nipro Corporation (Japan). , DaVita Inc. (USA), Nikkiso Co., Ltd. (Japan), Asahi Kasei Corporation (Japan), Cantel Medical Corporation (USA), Diaverum (Germany).

The hemodialysis services segment of the hemodialysis products and services market is expected to grow at the highest CAGR during the forecast period.

Based on the hemodialysis products and services market, the hemodialysis services segment is expected to grow at a significant rate during the forecast period. This reflects the growing demand for hemodialysis treatment among patients with end-stage renal disease and the hemodialysis services provided through collaboration with many dialysis centers to meet the increasing demand and improve patient outcomes. This can be attributed to the growth of hemodialysis service providers focused on expansion.

End-stage renal disease (ESRD) segment captures the largest market share in the hemodialysis and peritoneal dialysis market.

Based on disease indication, the hemodialysis and peritoneal dialysis market is segmented into acute kidney injury (AKI), end-stage end-stage renal disease (ESRD), and other disease indications such as electrolyte imbalance, fluid overload, and intoxication. ESRD segment held the largest market share during the forecast period.

story continues

The increasing incidence of chronic diseases such as diabetes, hypertension, and the increasing prevalence of chronic kidney disease have further increased the number of patients at risk of developing ESRD. Improved access to health services in developing countries, increased awareness of kidney disease, and increased use of hemodialysis treatments for ESRD management are likely to support growth in this sector.

North America accounted for the largest share in the hemodialysis and peritoneal dialysis market by region.

The global hemodialysis and peritoneal dialysis market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest regional market for hemodialysis and peritoneal dialysis products and services, while Asia-Pacific market is estimated to grow at the highest CAGR during the forecast period.

The largest share in North America is likely due to the high disease burden caused by chronic kidney disease, which is contributing to an increase in the number of patients requiring hemodialysis and peritoneal dialysis treatment. Presence of numerous dialysis service providers in North America, increasing number of dialysis centers offering hemodialysis, peritoneal dialysis, and home dialysis services, and favorable reimbursement policies in the region are driving the growth of the hemodialysis and peritoneal dialysis market in North America may be.

This report provides insight into the following guidelines:

• Analysis of key divers (increasing number of ESRD patients, technological advances in hemodialysis and peritoneal dialysis machines, increasing prevalence of diabetes and hypertension), constraints (high cost of hemodialysis treatment, reimbursement concerns in emerging countries, dialysis procedures) complications associated with hemodialysis), opportunities (emerging markets, gradual transition to home hemodialysis), and challenges (product recalls)

• Market Penetration: Comprehensive information on product portfolios offered by top players in the hemodialysis and peritoneal dialysis market

• Product Development/Innovation: Detailed insights into upcoming trends, R&D activities, and product launches in the hemodialysis and peritoneal dialysis market

• Market Development: Comprehensive information on profitable emerging regions

• Market Diversification: Thorough information on new products, growth regions, and recent trends in the hemodialysis and peritoneal dialysis market

• Competitive assessment: Detailed assessment of market segments, growth strategies, revenue analysis, and products of key market players.

Key attributes:

Market trend

driver

• Rising prevalence of chronic kidney disease

• Increased prevalence of diabetes and hypertension

• Technological advances and increased investment in research and development

restraints

opportunity

• Expanding growth opportunities in emerging countries

• Increase in the number of dialysis centers

• Growing interest in home hemodialysis

assignment

technical analysis

• key technology

• portable hemodialysis

• Complementary technology

• Biocompatible dialysis membrane

• Connected health sensors and remote sensors

• adjacent technology

• wearable artificial kidney

Featured companies

• Fresenius Medical Care AG

• Baxter

• Davita Co., Ltd.

• Nikkiso Co., Ltd.

• B. Brown SE

• medtronic

• Asahi Kasei Corporation

• Terumo Corporation

• Toray Medical Co., Ltd.

• Nipro Co., Ltd.

• Diabel Muab

• Dear Life SA

• Isopure Co., Ltd.

• Rockwell Medical Co., Ltd.

• Becton, Dickinson and Company

• JM's Co., Ltd.

• Almed Medical Products Co., Ltd.

• atlantic biomedical

• vascular mechanics

• Amecas

• Cook

• Medical Components Co., Ltd.

• polymedicure

• Kibe

• Outset Medical Co., Ltd.

For more information about this report, please visit: https://www.researchandmarkets.com/r/o00gmn

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.

attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900